Directory
>
Stephen Wargacki
Stephen Wargacki
Chief Science Officer | Aquestive Therapeutics
Caldwell, New Jersey, United States
Stephen Wargacki
Summary
Stephen Wargacki is a seasoned pharmaceutical executive with over 15 years of experience specializing in the strategic design and development of innovative drug delivery products and platforms. He currently serves as the Chief Science Officer at Aquestive Therapeutics, where he provides oversight and strategic direction across all phases of product development. His extensive expertise encompasses a wide range of scientific disciplines, including chemistry, clinical research, and process improvement. Stephen has a strong background in managing research and development teams and has held several leadership positions in the pharmaceutical industry. He is known for driving innovation and aligning product development with regulatory and clinical strategies. His academic credentials include a Ph.D. in Chemistry from the University of Tennessee, where he also contributed to research on polymer characterization. Beyond his technical skills, Stephen is adept at fostering collaboration among diverse teams and stakeholders.
Stephen Wargacki
Work Experience
Chief Science Officer at
Aquestive Therapeutics
April 2024 - Present
Senior Vice President Research Development at
Aquestive Therapeutics
January 2023 - Present
Vice President of Research and Development at Aquestive Therapeutics at
Aquestive Therapeutics
August 2019 - December 2022
Director of CMC at
Aquestive Therapeutics
November 2017 - August 2019
Director, Formulation R&D at
Aquestive Therapeutics
December 2015 - August 2019
Formulation Manager at
Aquestive Therapeutics
April 2015 - December 2015
Manager Research & Development at
LTS - Lohmann Therapy Systems
April 2013 - April 2015
Principal Scientist at
LTS - Lohmann Therapy Systems
January 2011 - April 2013
Research Scientist at
LTS - Lohmann Therapy Systems
January 2009 - December 2010
Program Scientist at
Gutierrez Ornamental Iron
January 2007 - January 2008
Research Scientist at
Air Force Research Laboratory
January 2005 - January 2007
Research Assistant at
University of Tennessee
January 2000 - January 2005
Stephen Wargacki
Education
University of Tennessee, Phd.
January 2000 - January 2005
Cumberland College, B.S.
January 1996 - January 1999
Frequently Asked Questions about Stephen Wargacki
What is Stephen Wargacki email address?
Stephen Wargacki's primary email address is *********@aquestive.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Stephen Wargacki work for?
Stephen Wargacki is a Chief Science Officer at Aquestive Therapeutics, a company specializing in Biological products, except diagnostic.
Where Stephen Wargacki graduated from?
Stephen Wargacki holds a degree in Chemistry from University of Tennessee.
How can I directly contact Stephen Wargacki?
To contact Stephen Wargacki directly, you can use the email address *********@aquestive.com. Complete contact information is available upon registration with Muraena.
Who is Stephen Wargacki?
Stephen Wargacki is a seasoned pharmaceutical executive with over 15 years of experience specializing in the strategic design and development of innovative drug delivery products and platforms. He currently serves as the Chief Science Officer at Aquestive Therapeutics, where he provides oversight and strategic direction across all phases of product development. His extensive expertise encompasses a wide range of scientific disciplines, including chemistry, clinical research, and process improvement. Stephen has a strong background in managing research and development teams and has held several leadership positions in the pharmaceutical industry. He is known for driving innovation and aligning product development with regulatory and clinical strategies. His academic credentials include a Ph.D. in Chemistry from the University of Tennessee, where he also contributed to research on polymer characterization. Beyond his technical skills, Stephen is adept at fostering collaboration among diverse teams and stakeholders.
Stephen`s contact details
*********@aquestive.com
*********@monosolrx.com
Colleagues
SVP Business Process & IT
Senior Vice President Business Process and IT
VP, Pricing & Market Access
Senior Vice President and Chief Financial Officer | NASDAQ: AQST | Oral Epinephrine
Chief Executive Officer
Chief Operating Officer
Chief Medical Officer
Vice President, Associate General Counsel, Corporate Compliance & Privacy Officer
VP, Regulatory Affairs